MarketInOut Stock Screener Log In | Sign Up

Mangalam Drugs & Organics Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:50
Mangalam Drugs & Organics Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization458.23 mln
Float14.85 mln

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-4.46
Highly reliable

Relative Strength

25 / 100
Underperforming

Debt / Equity

1.08
Elevated leverage

Pre-Tax Margin

-18%
Loss-making

ROE

-30.22
Deeply negative

Business Description

Mangalam Drugs & Organics Limited is a Mumbai-based pharmaceutical manufacturer founded in 1972 that produces and sells active pharmaceutical ingredients, chemical intermediates, and specialty chemicals across India. The company serves a broad range of medical needs, with products targeting conditions such as malaria, HIV, high blood pressure, inflammation, and bacterial infections. It also produces organic, inorganic, and heavy chemicals through its subsidiary operations.

Key Fundamentals

EPS-24.16
ROE-30.22
RPS147
ROIC-8.84
ROA-11.42
Interest Cover-1.69
EBITDA, mln-86.48
EV / EBITDA-18.55
EV / EBIT-6.06
Revenue, mln2,324
EV / Revenue0.69

Quote Details

Last 29.11
Change 0.29 (1.01%)
Open 28.99
Volume 13,243
Turnover 385,504
Average Volume 33,833

Financial Ratios

Pre-Tax Profit Margin-18
Current Ratio0.79
Price / Book0.47
Price / Tangible Book0.70
Price / Cash Flow5.94
Price / Free Cash Flow23.94
Debt / Equity1.08
Price / Sales0.21

Financial Strength

Altman Z-Score0.64
Piotroski F-Score 3 / 9
Beneish M-Score-4.46
Price to Intrinsic Value2.92
Shiller PE Ratio7.80

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.31% 28 / 100   
1 Month -8.55% 44 / 100   
2 Months 6.79% 80 / 100   
6 Months 4.71% 69 / 100   
1 Year -58.53% 5 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog